Secukinumab Provides Sustained Improvement in Nail Psoriasis and Inhibition of Radiographic Progression in Psa Patients With Nail Phenotype: 52-Week Results From a Phase 3 Study
Proceedings article published in 2020 by
Bruce Kirkham,
Peter Nash 
,
Philip J. Mease,
Alejandro C. Balsa,
Atul Singhal,
Erhard Quebe-Fehling,
Luminita Pricop,
Corine Gaillez
,
Philip J. Mease,
Alejandro C. Balsa,
Atul Singhal,
Erhard Quebe-Fehling,
Luminita Pricop,
Corine Gaillez
